Oregon Public Employees Retirement Fund’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Hold |
20,233
| – | – | 0.04% | 328 |
|
|
2025
Q1 | $2.24M | Sell |
20,233
-400
| -2% | -$44.2K | 0.04% | 353 |
|
|
2024
Q4 | $2.82M | Buy |
20,633
+117
| +0.6% | +$16K | 0.05% | 289 |
|
|
2024
Q3 | $2.36M | Sell |
20,516
-436
| -2% | -$50.2K | 0.04% | 356 |
|
|
2024
Q2 | $2.88M | Sell |
20,952
-3,643
| -15% | -$502K | 0.06% | 271 |
|
|
2024
Q1 | $3.39M | Sell |
24,595
-3,173
| -11% | -$438K | 0.07% | 247 |
|
|
2023
Q4 | $3.66M | Buy |
27,768
+341
| +1% | +$44.9K | 0.06% | 268 |
|
|
2023
Q3 | $3.09M | Sell |
27,427
-730
| -3% | -$82.1K | 0.04% | 401 |
|
|
2023
Q2 | $2.66M | Sell |
28,157
-13,267
| -32% | -$1.25M | 0.03% | 474 |
|
|
2023
Q1 | $4.19M | Buy |
41,424
+71
| +0.2% | +$7.19K | 0.05% | 341 |
|
|
2022
Q4 | $4.94M | Buy |
41,353
+13,455
| +48% | +$1.61M | 0.06% | 307 |
|
|
2022
Q3 | $2.96M | Buy |
27,898
+553
| +2% | +$58.7K | 0.04% | 393 |
|
|
2022
Q2 | $2.67M | Sell |
27,345
-3,000
| -10% | -$292K | 0.04% | 364 |
|
|
2022
Q1 | $2.85M | Sell |
30,345
-700
| -2% | -$65.6K | 0.03% | 551 |
|
|
2021
Q4 | $2.64M | Sell |
31,045
-793
| -2% | -$67.5K | 0.03% | 503 |
|
|
2021
Q3 | $3.05M | Sell |
31,838
-420
| -1% | -$40.3K | 0.03% | 426 |
|
|
2021
Q2 | $3.14M | Buy |
32,258
+916
| +3% | +$89.1K | 0.04% | 432 |
|
|
2021
Q1 | $3.05M | Buy |
31,342
+30,453
| +3,426% | +$2.96M | 0.04% | 416 |
|
|
2020
Q4 | $85K | Sell |
889
-8,300
| -90% | -$794K | ﹤0.01% | 1576 |
|
|
2020
Q3 | $884K | Sell |
9,189
-600
| -6% | -$57.7K | 0.01% | 828 |
|
|
2020
Q2 | $1.19M | Buy |
+9,789
| New | +$1.19M | 0.02% | 695 |
|